“Our long-term vision is to establish Singapore as a worldwide hub for allogeneic cell therapy”

How will the new investment accelerate the development of TAVST01? When do you plan to launch the product in the market?...

September 1, 2026 | Tuesday | Opinion
Singapore's MuseCell Innovations announces manufacturing collaboration with Celularity in US

US-based Celularity Inc., a longevity-focused regenerative and cellular medicine company, and Singaporean startup M...

August 27, 2026 | Thursday | News
Cytrellis launches full-body skin resurfacing technology in Australia

Cytrellis Biosystems, Inc., a medical aesthetics company bridging the gap in skin health and restoration, has annou...

August 27, 2026 | Thursday | News
PENTAX Medical and MAGENTIQ EYE expand global partnership to advance AI-assisted colonoscopy

Japan-based PENTAX Medical, a HOYA Group company, has announced the expansion of its partnership with MAGENTIQ EYE, exte...

August 27, 2026 | Thursday | News
Shimadzu invests in OptQC to advance next-generation R&D infrastructure for drug discovery

Japan-based Shimadzu Corporation has invested in OptQC Inc., a startup originating from The University of Tokyo, through...

August 26, 2026 | Wednesday | News
Korea's SK Biopharmaceuticals partners with Biohaven for epilepsy treatment

US-based Biohaven and SK Biopharmaceuticals, based in South Korea, have announced a strategic global licensing and ...

August 26, 2026 | Wednesday | News
China's Haisco Pharma enters into agreement worth $1.5 B with US-based Sentivera

Haisco Pharmaceutical Group Co. has entered into an exclusive licensing agreement with Sentivera, a new US venture found...

August 26, 2026 | Wednesday | News
Advent acquires majority stake in New Zealand Clinical Research Group

US-based Advent, a leading global private equity investor, has signed a definitive agreement to acquire a majority share...

August 26, 2026 | Wednesday | News
GC Biopharma's Hunter Syndrome treatment 'Hunterase' receives drug approval in India and Taiwan

GC Biopharma, a leading global pharmaceutical company based in South Korea, has announced that its Hunter syndrome treat...

August 24, 2026 | Monday | News
Korea's Hanmi Pharm signs $2.3 B deal with Genentech for novel obesity therapy

South Korea-based Hanmi Pharm has entered into an exclusive licensing agreement with Genentech, a member of the Roche Gr...

August 25, 2026 | Tuesday | News
China Biotech’s Global Breakout: Innovation, Deals and the Next Investment Cycle

China’s biotech and pharmaceutical sector is entering a new phase of global relevance. A surge in out-licensing de...

August 24, 2026 | Monday | Influencers
Global CRO Novotech strengthens presence in Japan with new Tokyo office

Novotech, a leading global biotech CRO and full-service clinical research organisation, has strengthened its established...

August 24, 2026 | Monday | News
Taiwan's Lotus Pharma inks biosimilars agreement with Alvotech for US and selected Asian markets

Taiwan-based Lotus Pharmaceutical Co. has announced a strategic licensing and commercialisation agreement with Alvotech,...

August 25, 2026 | Tuesday | News
Korea's Rznomics joins Lilly Gateway Labs in US to accelerate RNA Therapeutics

South Korea based Rznomics Inc, a biopharmaceutical company specialising in the development of RNA-based gene therapies,...

August 24, 2026 | Monday | News
Genentech injects $750 M in new device fill-finish manufacturing facility in US

Genentech, a member of the Roche Group, has announced plans to invest approximately $750 million in a new device fill-fi...

August 21, 2026 | Friday | News
Charles River Laboratories collaborates with Taiwan's Medigen Vaccine Biologics Corp

US-based Charles River Laboratories International, and Medigen Vaccine Biologics Corp. (MVC), headquartered in Taiwan, h...

August 24, 2026 | Monday | News
Taiwan's Astron Medtech receives Presidential Award, accelerates US commercial expansion

Aztron Medtech Corporation, a US-based orthopaedic device company, has announced that its Taiwan subsidiary, Astron Medt...

August 21, 2026 | Friday | News
Australia's OncoSil Medical secures US FDA approval for cancer radiation device

Australia-based OncoSil Medical, a medical device company developing targeted radiation therapies for difficult-to-treat...

August 21, 2026 | Friday | News
Ono Pharma's Opdivo intravenous infusion wins additional approval in Taiwan

Japan-based Ono Pharmaceutical has announced that Ono Pharma Taiwan, a Taiwanese subsidiary of Ono, has received the add...

August 20, 2026 | Thursday | News
Japan's Chugai Pharma signs exclusive license agreement with GSK for anti-dengue virus antibody AID351

Japan-based Chugai Pharmaceutical has signed an exclusive license agreement with British pharma firm GlaxoSmithKline (GS...

August 20, 2026 | Thursday | News
Mankind Pharma inks diabetes deal with Chongqing Chenan Biopharma

Mankind Pharma, one of India’s leading pharmaceutical companies, has entered into an exclusive in-licensing and ma...

August 20, 2026 | Thursday | News
Next-Gen Cell Therapy Starts with the Right T Cells

  As cell therapies advance towards greater clinical sophistication and commercial scale, the focus is shifting fr...

August 19, 2026 | Wednesday | Influencers
Korean medtech player Rayence launches portable X-ray diagnostic solutions

Rayence, a South Korea-based leader in digital X-ray detectors and medical imaging solutions, has announced the launch o...

August 20, 2026 | Thursday | News
Chinese startup Enginprime Medical closes $12 M Series A financing

Enginprime Medical, a developer of percutaneous ventricular assist device (pVAD) technology, has announced the closing o...

August 18, 2026 | Tuesday | News
LEO Pharma buys Tanabe’s rare disease drug dersimelagon for $435 M

LEO Pharma, a global leader in medical dermatology delivering innovative solutions for skin disease, has entered into an...

August 18, 2026 | Tuesday | News